» Articles » PMID: 33363056

CSF Levels of Elongation Factor Tu Is Associated With Increased Mortality in Malawian Adults With Meningitis

Abstract

Background: Mortality from bacterial meningitis, predominately caused by , exceeds 50% in sub-Saharan African countries with high HIV prevalence. Underlying causes of high mortality are poorly understood. We examined the host and pathogen proteome in the CSF of adults with proven pneumococcal meningitis (PM), testing if there was an association between differentially expressed proteins and outcome.

Materials/methods: CSF proteomes were analyzed by quantitative Mass-Spectrometry. Spectra were identified using the Swissprot human and TIGR4 pneumococcal protein libraries. Proteins were quantitated and analyzed against mortality. Unique proteins in PM were identified against published normal CSF proteome. Random-Forest models were used to test for protein signatures discriminating outcome. Proteins of interest were tested for their effects on growth and neutrophil opsonophagocytic killing of .

Results: CSF proteomes were available for 57 Adults with PM (median age 32 years, 60% male, 70% HIV-1 co-infected, mortality 63%). Three hundred sixty individual human and 23 pneumococcal proteins were identified. Of the human protein hits, 30% were not expressed in normal CSF, and these were strongly associated with inflammation and primarily related to neutrophil activity. No human protein signature predicted outcome. However, expression of the essential protein Elongation Factor Tu (EF-Tu) was significantly increased in CSF of non-survivors [False Discovery Rate (q) <0.001]. Expression of EF-Tu was negatively cocorrelated against expression of Neutrophil defensin (r 0.4 p p < 0.002), but not against complement proteins C3 or Factor H. , addition of EF-Tu protein impaired neutrophil killing in CSF.

Conclusions: Excessive EF-Tu protein in CSF was associated with reduced survival in meningitis in a high HIV prevalence population. We show EF-Tu may inhibit neutrophil mediated killing of in CSF. Further mechanistic work is required to better understand how avoids essential innate immune responses during PM through production of excess EF-Tu.

Citing Articles

Addition of daptomycin for the treatment of pneumococcal meningitis: protocol for the AddaMAP study.

Chavanet P, Fournel I, Bourredjem A, Piroth L, Blot M, Sixt T BMJ Open. 2023; 13(7):e073032.

PMID: 37491088 PMC: 10373719. DOI: 10.1136/bmjopen-2023-073032.


meningitis and the CNS barriers.

Gil E, Wall E, Noursadeghi M, Brown J Front Cell Infect Microbiol. 2023; 12:1106596.

PMID: 36683708 PMC: 9845635. DOI: 10.3389/fcimb.2022.1106596.


Targeted Transcriptomic Screen of Pneumococcal Genes Expressed during Murine and Human Infection.

Basset A, Wall E, Mitsi E, Deshusses C, Daly R, Pojar S Infect Immun. 2022; 90(7):e0017522.

PMID: 35674445 PMC: 9302103. DOI: 10.1128/iai.00175-22.


Editorial: Host-Pathogen Interaction in the Central Nervous System.

Barichello T, Iovino F Front Cell Infect Microbiol. 2022; 11:790761.

PMID: 35004356 PMC: 8740900. DOI: 10.3389/fcimb.2021.790761.

References
1.
Barichello T, Lemos J, Generoso J, Cipriano A, Milioli G, Marcelino D . Oxidative stress, cytokine/chemokine and disruption of blood-brain barrier in neonate rats after meningitis by Streptococcus agalactiae. Neurochem Res. 2011; 36(10):1922-30. DOI: 10.1007/s11064-011-0514-2. View

2.
Savonius O, Helve O, Roine I, Andersson S, Saukkoriipi A, Gonzalez Mata A . Cerebrospinal Fluid Cathelicidin Correlates With the Bacterial Load and Outcomes in Childhood Bacterial Meningitis. Pediatr Infect Dis J. 2017; 37(2):182-185. DOI: 10.1097/INF.0000000000001744. View

3.
Wall E, Mukaka M, Scarborough M, Ajdukiewicz K, Cartwright K, Nyirenda M . Prediction of Outcome From Adult Bacterial Meningitis in a High-HIV-Seroprevalence, Resource-Poor Setting Using the Malawi Adult Meningitis Score (MAMS). Clin Infect Dis. 2016; 64(4):413-419. PMC: 5399948. DOI: 10.1093/cid/ciw779. View

4.
Matthias K, Roche A, Standish A, Shchepetov M, Weiser J . Neutrophil-toxin interactions promote antigen delivery and mucosal clearance of Streptococcus pneumoniae. J Immunol. 2008; 180(9):6246-54. DOI: 10.4049/jimmunol.180.9.6246. View

5.
Olaya-Abril A, Prados-Rosales R, McConnell M, Martin-Pena R, Gonzalez-Reyes J, Jimenez-Munguia I . Characterization of protective extracellular membrane-derived vesicles produced by Streptococcus pneumoniae. J Proteomics. 2014; 106:46-60. DOI: 10.1016/j.jprot.2014.04.023. View